
Global & South Africa Cancer Therapeutics Market to 2031
Description
South Africa, one of the leading economies in the Middle East and Africa, recorded a GDP of approximately US$377.78 billion in 2023. Healthcare spending represents around 8.5% of the country’s GDP, making it the second-largest component of national expenditure. With both government and private sector investments increasing to enhance healthcare infrastructure, there is a growing demand for therapeutic solutions. As home to one of Africa’s most advanced healthcare systems, South Africa continues to invest significantly in cancer research and treatment innovations. Factors such as an aging population, improved access to medical services, and advancements in diagnostic tools are driving the need for effective cancer therapies.
Cancer is among the primary causes of mortality in South Africa, with breast, prostate, cervical, and lung cancers being the most prevalent. According to GLOBOCAN 2020, the country reported approximately 108,168 new cancer cases and 56,802 cancer-related deaths that year. In response to the rising cancer burden, the South African government is actively implementing strategies aimed at expanding access to care and supporting therapeutic advancements. These strategies focus on cancer prevention, early detection, and enhancing treatment options to improve patient outcomes. National health policies have also been introduced to strengthen cancer care services. For example, the proposed National Health Insurance (NHI) scheme aims to deliver comprehensive healthcare coverage to all citizens, including cancer treatments, thereby facilitating broader access to essential and potentially life-saving therapies.
Cancer is among the primary causes of mortality in South Africa, with breast, prostate, cervical, and lung cancers being the most prevalent. According to GLOBOCAN 2020, the country reported approximately 108,168 new cancer cases and 56,802 cancer-related deaths that year. In response to the rising cancer burden, the South African government is actively implementing strategies aimed at expanding access to care and supporting therapeutic advancements. These strategies focus on cancer prevention, early detection, and enhancing treatment options to improve patient outcomes. National health policies have also been introduced to strengthen cancer care services. For example, the proposed National Health Insurance (NHI) scheme aims to deliver comprehensive healthcare coverage to all citizens, including cancer treatments, thereby facilitating broader access to essential and potentially life-saving therapies.
Table of Contents
100 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. South Africa Cancer Therapeutics Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Cancer Therapeutics Market Key Market Dynamics
- 5.1 Cancer Therapeutics Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. South Africa Cancer Therapeutics Market – Analysis
- 6.1 South Africa Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
- 6.2 South Africa Cancer Therapeutics Market Revenue and Forecast Analysis
- 7. South Africa Cancer Therapeutics Market Analysis – by Therapy Types
- 7.1 South Africa Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
- 8. South Africa Cancer Therapeutics Market Analysis – by Indications
- 8.1 South Africa Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
- 9. South Africa Cancer Therapeutics Market Analysis – by Distribution Channel
- 9.1 South Africa Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Bristol-Myers Squibb Co
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 AbbVie Inc
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Johnson & Johnson
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Pfizer Inc
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 AstraZeneca Plc
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Merck KGaA
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Novartis AG
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Astellas Pharma Inc
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Eli Lilly and Co
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. South Africa Cancer Therapeutics Market Segmentation
- Table 2. List of Vendors
- Table 3. South Africa Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
- Table 4. South Africa Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. South Africa Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
- Table 6. South Africa Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
- Table 7. South Africa Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
- Table 8. South Africa Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
- Table 9. South Africa Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
- Table 10. South Africa Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. South Africa Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.